Plain-English translation of NCT07312409 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether taurine, a naturally occurring amino acid, can help improve blood vessel function and reduce symptoms like lightheadedness in people living with Long COVID. Recent research suggests that people with Long COVID often have low taurine levels, and that boosting these levels might help with symptom recovery. The researchers want to see if taking this medication for 12 weeks makes a real difference in how blood vessels work and how your body responds when you stand up.
Long COVID affects millions of people, causing ongoing symptoms like dizziness and poor blood vessel function months after the initial infection. Early research suggests this medication could help restore blood vessel health and reduce these bothersome symptoms, but it hasn't been tested specifically in Long COVID patients yet.
You likely qualify if…
You likely don't qualify if…
You will be assigned to either take the supplement daily for 12 weeks or to a control group that does not take it. Either way, you'll visit York University for testing before you start, and again after 12 weeks. During these visits, researchers will measure how well your blood vessels are working and test how your body responds when you stand up (using a special tilting table). The whole process takes about 12 weeks from start to finish.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Canada